openPR Logo
Press release

Adenovirus Diagnostic Testing Market Growth To Be Fuelled by Growing Research and Development Of Technologies

10-11-2018 12:29 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Adenovirus-Diagnostic-Testing-Market

Adenovirus-Diagnostic-Testing-Market

Adenovirus is one of the DNA viruses that are considered to be a major cause of febrile illness, primarily among children. Individuals and Infants with weak immune systems, cardiac disease or chronic respiratory problems are at higher risk of developing adenovirus infection, however, most infections are not severe. Adenovirus is a communicable infection, as it is an air-borne diseases and can spread from infected person to others by coughing and sneezing, and close contact such as shaking or touching hands. Adenovirus can cause pneumonia, acute respiratory disease, epidemic kerato-conjunctivitis, acute follicular conjunctivitis, gastroenteritis, and cystitis. Among infants, pharyngeal-conjunctival and pharyngitis fever are commonly caused by Adenovirus.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1678

In 2016, a study conducted by Barcelona Center for International Health Research and University of Barcelona, on children suffering from pneumonia, suggests that adenovirus is the second-most common respiratory virus causing pneumonia. Some adenoviruses can also spread through the infected person’s stools, for instance, during diaper changing. Adenovirus can also spread through water such as swimming pools, however, this is less common. Adenovirus infections can be usually diagnose by molecular methods or can be detected with polymerase chain reaction (PCR), serology, antigen detection or viral culture. Others emerging technologies such as liposomes, monoclonal antibodies, chromatography, flow cytometry, and gel micro droplets are also of vital use in diagnosis of adenovirus infection.

Adenovirus Diagnostic Testing Market - Key Players Operating Global Market
Affymetrix, Inc., Becton Dickinson and company, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Novartis AG, Qiagen N.V., DiaSorin Inc., Abbott Laboratories, and bioMerieux.

Adenovirus Diagnostic Testing Market – Driver

Adenoviruses are associated with a variety of nonspecific manifestations and clinical syndromes, thus diagnosis based upon clinical criteria alone is challenging. Diagnosis is most accurate when the infection shows outbreak symptoms or individuals show serious disease manifestations. Validation of adenovirus infection is essential for identifying the most appropriate treatment to establish a prognosis and initiate infection control measures by using correct antiviral agents, thus making diagnosis of these viruses a vital procedure. This in turn, is expected to augment growth of the adenovirus diagnostic testing market. Generally, there are two types of adenoviruses namely, Type 4 and Type 7 that caused severe outbreaks of respiratory illness, especially among military recruits. Thus, adenovirus vaccine, containing Type 4 and Type 7, is thus approved for military personnel aged 17 to 50 years from 1971, to protect them against the illness caused by these two viruses.

In the recent past, adenovirus infections were diagnose by cell culture, as the virus replicates efficiently in cell cultures. Monoclonal antibodies are also used to detect infected cells using direct fluorescence antibody assays. Amplification and detection of adenovirus DNA by polymerase chain reaction methods are also gaining popularity as laboratory methods to determine adenovirus infection. The rapid detection and quantitation of adenovirus DNA, especially by a sensitive PCR technique is expected to aid in the diagnosis and treatment monitoring of adenovirus infections, particularly in immunocompromised patients. This in turn, is expected to boost growth of the adenovirus diagnostic testing market during the forecast period.

Request for Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1678

Adenovirus Diagnostic Testing Market – Taxonomy

By Assay Type:

PCR Assay Kits
Antigen Detection Kits
Other Assay Kits

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adenovirus Diagnostic Testing Market Growth To Be Fuelled by Growing Research and Development Of Technologies here

News-ID: 1296666 • Views:

More Releases from Coherent Market Insights - Biotechnology

Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 Period till 2027 | Medtronic Plc, Hill-Rom Holdings, iRhythm Technologies
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast Period 2017 - 2025 And The Top Competitors Are Crown Bioscience, ProSpec Tany TechnoGene, BPS Bioscience, Sigma Aldrich Company, Novoprotein Scientific
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players Biocon, Pfizer Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca, Novartis AG, and Merck & Co
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

All 5 Releases


More Releases for Adenovirus

Adenovirus Nephritis Market Emerging Trends and Growth Prospects 2034
Introduction Adenovirus nephritis is a rare but severe kidney condition often occurring in immunocompromised patients, such as transplant recipients or individuals undergoing intensive chemotherapy. It is characterized by viral infection of renal tissue, leading to nephritis, graft dysfunction, or renal failure. Adenovirus nephritis is particularly challenging to manage because of the lack of specific approved therapies, the high-risk patient population it affects, and the delicate balance required between antiviral treatment and
Oncolytic Adenovirus Market Dynamics, Key Players and Commercial Opportunities
Oncolytic adenovirus therapy is an innovative and promising form of cancer immunotherapy that utilizes genetically modified adenoviruses to selectively infect and kill cancer cells. This approach, known as oncolytic virotherapy, harnesses the power of viruses to target and destroy tumors while sparing healthy cells, reducing side effects compared to traditional treatments such as chemotherapy and radiation. Adenoviruses are chosen due to their ability to infect a wide variety of human
Oncolytic Adenovirus Market Innovations, Market Dynamics and Future Opportunitie …
Oncolytic adenoviruses represent a cutting-edge approach in cancer treatment that leverages modified adenoviruses to selectively target and kill cancer cells while sparing healthy tissues. These genetically modified viruses are designed to infect and replicate within tumor cells, causing tumor cell lysis and simultaneously stimulating the body's immune response against the cancer. This therapeutic modality, known as oncolytic virotherapy, is gaining attention as a promising cancer treatment, particularly for solid tumors
Global Oncolytic Adenovirus Market Analysis 2025-2030: Growth Drivers, Challenge …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. How Big Is the Oncolytic Adenovirus Market Size Expected to Be by 2034? The market size for the oncolytic adenovirus has seen a dramatic increase in recent times. Projected to rise from $122.31 billion in 2024 to a substantial $132.87 billion in 2025, it boasts a compound annual growth rate (CAGR) of
Adenovirus Antigen Rapid Tests Market Key Players, Share and Forecast Outlook
On May 8, 2025, Exactitude Consultancy., Ltd. released a research report titled "Adenovirus Antigen Rapid Tests Market". This report covers the global Adenovirus Antigen Rapid Tests market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future
Rapid Adenovirus Testing Market Size, Status, Top Players, Trends and Forecast 2 …
According to latest research by Persistence Market Research, Rapid adenovirus testing market is set to witness steady growth during 2021-2031. Need for early diagnosis of chronic diseases expected to drive the market. Adenovirus induces the most common respiratory illnesses and outbreaks can occur throughout the year. People with compromised immunity are at increased risk of serious illness caused by adenovirus infection. Adenovirus is a very common infection and according to WHO